Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$63.24 USD
-0.29 (-0.46%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $63.24 0.00 (0.00%) 6:26 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Income Statements
Fiscal Year end for Exact Sciences Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,500 | 2,084 | 1,767 | 1,491 | 876 |
Cost Of Goods | 654 | 574 | 459 | 354 | 217 |
Gross Profit | 1,846 | 1,510 | 1,308 | 1,137 | 660 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,061 | 2,103 | 2,164 | 1,905 | 893 |
Income After Depreciation & Amortization | -215 | -594 | -856 | -768 | -234 |
Non-Operating Income | 33 | -19 | 32 | 7 | 27 |
Interest Expense | 19 | 20 | 19 | 96 | 62 |
Pretax Income | -202 | -633 | -843 | -857 | -269 |
Income Taxes | 2 | -9 | -247 | -9 | -185 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -204 | -624 | -596 | -849 | -84 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -204 | -624 | -596 | -849 | -84 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -371 | -644 | -321 | -149 |
Depreciation & Amortization (Cash Flow) | 207 | 223 | 212 | 447 | 85 |
Income After Depreciation & Amortization | -215 | -594 | -856 | -768 | -234 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 180.14 | 176.35 | 171.35 | 151.14 | 131.26 |
Diluted EPS Before Non-Recurring Items | -1.13 | -3.54 | -3.48 | -1.38 | -1.49 |
Diluted Net EPS (GAAP) | -1.13 | -3.54 | -3.48 | -5.61 | -0.64 |
Fiscal Year end for Exact Sciences Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 646.89 | 628.34 | 622.09 | 602.45 |
Cost Of Goods | NA | 171.87 | 168.53 | 156.99 | 156.87 |
Gross Profit | NA | 475.02 | 459.81 | 465.10 | 445.58 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 542.86 | 452.97 | 542.04 | 522.68 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -67.84 | 6.84 | -76.94 | -77.10 |
Non-Operating Income | NA | 25.33 | 2.07 | 4.83 | 0.49 |
Interest Expense | NA | 7.87 | 7.87 | 7.82 | -4.11 |
Pretax Income | NA | -50.38 | 1.04 | -79.92 | -72.49 |
Income Taxes | NA | -0.61 | 0.25 | 1.11 | 1.66 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -49.77 | 0.79 | -81.03 | -74.15 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -49.77 | 0.79 | -81.03 | -74.15 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 181.11 | 184.08 | 180.20 | 178.57 |
Diluted EPS Before Non-Recurring Items | NA | -0.27 | 0.00 | -0.45 | -0.42 |
Diluted Net EPS (GAAP) | NA | -0.26 | 0.00 | -0.45 | -0.42 |